Clinical trial
Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use
NCT00430573 · Boston University Charles River Campus, Other · Terminated
Key facts
| NCT number | NCT00430573 |
|---|---|
| Title | Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use |
| Official title | Placebo-Controlled Evaluation of the Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use |
| Lead sponsor | Boston University Charles River Campus, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH Massachusetts General Hospital |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Substance-Related Disorders |
| Intervention type | Drug |
| Interventions | D-cycloserine, Placebo |
| Enrollment | 15 |
| Start date | Feb 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Feb 2, 2007 |
| Last update posted | May 17, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: